• Prescription Drug and Alcohol Use Disorders

    Purchase This Edition 

    Online access only

    #478: Prescription Drug and
    Alcohol Use Disorders
    March 2019

    Member: $39.95
    Nonmember: $44.95

    Note: the price you will see in the cart 
    will be the price you will pay.

    FP Essentials is a monthly subscription containing authoritative, unbiased, and peer-reviewed clinical information—without any advertisements.

    Purchase this individual edition for online access to its content, and earn up to 5 CME credits upon completion of the quiz. Online access for this edition and CME credit available until March 14, 2021.

    In This Edition

    • Review and follow the Centers for Disease Control and Prevention recommendations for safe prescribing of opioids.
    • Identify nonopioid first-line treatment of chronic noncancer pain.
    • Summarize the criteria for diagnosing opioid use disorder and be able to distinguish it from uncomplicated opioid dependence.
    • Describe why methadone, buprenorphine, and intramuscular naltrexone are the recommended pharmacotherapies for opioid use disorder.
    • List some prescription and nonprescription drugs with which nonmedical use can occur.
    • Describe appropriate tools to assess for nonmedical use, including drug screening tests and state prescription drug monitoring program data.
    • Identify the three screening tests that are recommended when assessing for unhealthy alcohol use and choose one or more of them to screen all adults.
    • Explain why acamprosate and naltrexone are firstline treatments for alcohol use disorder.

    Access your editions in the AAFP app. You may also try a free digital sample.

    Subscribe to FP Essentials

    Subscribe and receive access to peer-reviewed, ad-free monographs. Eligible for up to 60 AAFP Prescribed credits with a yearly subscription. Available in print or online. Learn more.